(2020). Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. Oncolytic Virotherapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib."
Oncolytic Virotherapy 2020.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib."
Oncolytic Virotherapy, 2020.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.